SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-14-019329
Filing Date
2014-03-31
Accepted
2014-03-31 15:33:59
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v371702_10k.htm 10-K 784451
2 EXHIBIT 10.30 v371702_ex10-30.htm EX-10.30 171263
3 EXHIBIT 23.1 v371702_ex23-1.htm EX-23.1 2385
4 EXHIBIT 31.1 v371702_ex31-1.htm EX-31.1 9069
5 EXHIBIT 32.1 v371702_ex32-1.htm EX-32.1 4362
6 GRAPHIC tpg18.jpg GRAPHIC 26587
  Complete submission text file 0001144204-14-019329.txt   7461118

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ttnp-20131231.xml EX-101.INS 1156737
8 XBRL TAXONOMY EXTENSION SCHEMA ttnp-20131231.xsd EX-101.SCH 67048
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ttnp-20131231_cal.xml EX-101.CAL 44665
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ttnp-20131231_def.xml EX-101.DEF 322597
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ttnp-20131231_lab.xml EX-101.LAB 435891
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ttnp-20131231_pre.xml EX-101.PRE 394086
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27436 | Film No.: 14729790
SIC: 2836 Biological Products, (No Diagnostic Substances)